29 results on '"Tabada, Grace"'
Search Results
2. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity
3. Large-scale identification of aortic stenosis and its severity using natural language processing on electronic health records
4. Covid-19 and Risk of Venous Thromboembolism in Ethnically Diverse Populations
5. Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications
6. Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation
7. Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
8. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease
9. Short-Term Outcomes and Factors Associated With Adverse Events Among Adults Discharged From the Emergency Department After Treatment for Acute Heart Failure
10. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease
11. Abstract 14470: Recalibration of the ACC/AHA ASCVD Risk Estimator for Primary Prevention in a Large, Multiethnic Community-Based Population
12. Abstract 14167: Incidence and Predictors of Anemia Complicating Heart Failure: The RBC HEART Study
13. Approach to Multimorbidity Burden Classification and Outcomes in Older Adults With Heart Failure.
14. QUANTITATIVE AORTIC STENOSIS PARAMETERS AND LONG-TERM OUTCOMES: RESULTS FROM THE KP-VALVE PROJECT
15. PHYSICIAN ASSESSMENT OF AORTIC STENOSIS SEVERITY AND LONG-TERM OUTCOMES: RESULTS FROM THE KP-VALVE PROJECT
16. COVID-19 and Risk of VTE in Ethnically Diverse Populations.
17. COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use.
18. Contemporary Reevaluation of Race and Ethnicity With Outcomes in Heart Failure.
19. Influence of Multimorbidity on Burden and Appropriateness of Implantable Cardioverter‐Defibrillator Therapies.
20. RE-EVALUATION OF RACE AND ETHNICITY WITH ADVERSE OUTCOMES IN HEART FAILURE
21. LEVELS OF OBESITY AND ACCURACY OF THE ATHEROSCLEROTIC CARDIOVASCULAR RISK EQUATION IN A LARGE COMMUNITY-BASED COHORT
22. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
23. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.
24. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
25. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
26. NATURAL HISTORY OF AORTIC STENOSIS IN A LARGE INTEGRATED HEALTH CARE DELIVERY SYSTEM.
27. Abstract 12623: A New ASCVD Risk Estimator is More Accurate Than the ACC/AHA Pooled Cohort Equation in Four Diverse Community-Based Populations in the U.S. and Canada.
28. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia.
29. Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.